Tue, Jul 22, 2014, 6:03 AM EDT - U.S. Markets open in 3 hrs 27 mins

Recent

% | $
Click the to save as a favorite.

Celldex Therapeutics, Inc. Message Board

  • mymandon mymandon Jan 28, 2013 6:31 PM Flag

    A look back at Celldex recent stock price catalysts

    Catalyst a) over the last 3 weeks of November 2012 Celldex price ran up from just over $5/share to just over $6 (up~20%) in anticipation of the CDX-011 final data. Noteworthy, was the short selling in the week prior to the data release that did briefly drop the price to just over $5.50 right before the data release. Catalyst b) CDX-011 data final phase II data release on December 10th sent share up to just over $7 (up ~25%) before trading in a high $6 range through the three weeks leading to the end of the year. Catalyst c) Fiscal cliff resolution on January 2nd was good for additional 25 cents (up ~5%). Catalyst d) Cantor increased price target to $13 January 10th added additional 25 cents (up ~3.5%). Catalyst e) Roth Capital price target upgrade to $16 in January 23rd provided incremental increase that has been given up over the last week. So , in summary Celldex stock price in last 12 weeks (from early November to end of January) has increase from $5 to $7.25 (~45% up) on these catalysts and f) the hidden catalyst of growing balance sheet due to the Cantor ATM facility raising ~40 million in cash over this time period. I’d say this would classify Celldex as a hot biotech stock.

    Sentiment: Strong Buy

 
CLDX
13.00+0.15(+1.17%)Jul 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Netflix, Inc.
NasdaqGSMon, Jul 21, 2014 4:00 PM EDT